Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06293755
Other study ID # COA022/66
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date February 28, 2024
Est. completion date June 25, 2024

Study information

Verified date February 2024
Source Dhurakij Pundit University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of microneedle patch with botulinum toxin for improving enlarged pores.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 16
Est. completion date June 25, 2024
Est. primary completion date March 5, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years old and concerned about enlarged pores - Have pore size 0.3-0.6 mm - Have pore parameter in each other side of faces not different more than 5% Exclusion Criteria: - Any neuromuscular condition - Pregnancy or breast feeding - History of allergy : Botulinum toxin, topical anesthesia - History of keloid or hypertrophic scar - History of coagulation or receiving medication that causes coagulation disorder - Using drugs that have interaction with Botulinum toxin - Using topical medication that improves enlarged pores in 1 month - Taking medication that improves enlarged pores in 1 month - Receiving the laser/treatment/chemical peeling in 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Microneedle patch
with 20 units botulinum toxin
Intradermal injection
with 20 units botulinum toxin

Locations

Country Name City State
Thailand Dhurakij Pundit University Lak Si Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Dhurakij Pundit University

Country where clinical trial is conducted

Thailand, 

References & Publications (1)

Salem RM, Salah SAE, Ibrahim SE. Microbotox injection versus its topical application following microneedling in the treatment of wide facial pores: A split face comparative study. J Cosmet Dermatol. 2023 Apr;22(4):1249-1255. doi: 10.1111/jocd.15590. Epub — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of enlarged pores as measured by VISIA (pores parameter) and using pore score the used pore scores, patients with visible pores took the score "1," and those with enlarged pores took "2." When black heads were embedded on facial pores the score was "3." The scores were assessed by 2 investigators who were blinded to the treatment used on each side. Post-intervention, week 4 and week 16
See also
  Status Clinical Trial Phase
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT05254210 - Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device N/A
Active, not recruiting NCT05784363 - A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face Phase 1
Recruiting NCT04471948 - The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study N/A
Active, not recruiting NCT02544958 - Er:YAG Laser for Treatment of Enlarged Pores N/A
Recruiting NCT05987319 - Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions N/A